Protein kinases and phosphatases in the control of cell fate

Enzyme Research

Volumn 2011, Issue 1, 2011, Pages

  Bononi, Angela ^a   Agnoletto, Chiara ^a   De Marchi, Elena ^a   Marchi, Saverio ^a   Patergnani, Simone ^a   Bonora, Massimo ^a   Giorgi, Carlotta ^a   Missiroli, Sonia ^a   Poletti, Federica ^a   Rimessi, Alessandro ^a   Pinton, Paolo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; ISOPROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; UBIQUITIN PROTEIN LIGASE NEDD4;

APOPTOSIS; CELL DIVISION; CELL FATE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW;

EID: 84857895434     PISSN: 20900406     EISSN: 20900414     Source Type: Journal    
DOI: 10.4061/2011/329098     Document Type: Review

References (278)

1. Julien S. G., Dubé N., Hardy S., Tremblay M. L., Inside the human cancer tyrosine phosphatome. Nature Reviews Cancer 2011 11 1 35 49 2-s2.0-78650601353 10.1038/nrc2980
2. Ruela-de-Sousa R. R., Queiroz K. C., Peppelenbosch M. P., Fuhler G. M., Reversible phosphorylation in haematological malignancies: potential role for protein tyrosine phosphatases in treatment? Biochimica et Biophysica Acta 2010 1806 2 287 303
3. Zhang H., Zha X., Tan Y., Hornbeck P. V., Mastrangelo A. J., Alessi D. R., Polakiewicz R. D., Comb M. J., Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. Journal of Biological Chemistry 2002 277 42 39379 39387 2-s2.0-0037131411 10.1074/jbc.M206399200 (Pubitemid 35190911)
4. Bauman A. L., Scott J. D., Kinase- and phosphatase-anchoring proteins: Harnessing the dynamic duo. Nature Cell Biology 2002 4 8 E203 E206 2-s2.0-0036045812 10.1038/ncb0802-e203
5. Dhillon A. S., Hagan S., Rath O., Kolch W., MAP kinase signalling pathways in cancer. Oncogene 2007 26 22 3279 3290 2-s2.0-34248583886 10.1038/sj.onc.1210421 (Pubitemid 46763021)
6. Engelman J. A., Luo J., Cantley L. C., The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nature Reviews Genetics 2006 7 8 606 619 2-s2.0-33746257209 10.1038/nrg1879 (Pubitemid 44100518)
7. Carracedo A., Ma L., Teruya-Feldstein J., Rojo F., Salmena L., Alimonti A., Egia A., Sasaki A. T., Thomas G., Kozma S. C., Papa A., Nardella C., Cantley L. C., Baselga J., Pandolfi P. P., Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. Journal of Clinical Investigation 2008 118 9 3065 3074 2-s2.0-51349164790 10.1172/JCI34739
8. Carracedo A., Pandolfi P. P., The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 2008 27 41 5527 5541 2-s2.0-51849084360 10.1038/onc.2008.247
9. Kornblau S. M., Womble M., Yi H. Q., Jackson C. E., Chen W., Konopleva M., Estey E. H., Andreeff M., Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia. Blood 2006 108 7 2358 2365 2-s2.0-33749337234 10.1182/blood-2006-02-003475 (Pubitemid 44497520)
10. McCubrey J. A., Steelman L. S., Chappell W. H., Abrams S. L., Wong E. W. T., Chang F., Lehmann B., Terrian D. M., Milella M., Tafuri A., Stivala F., Libra M., Basecke J., Evangelisti C., Martelli A. M., Franklin R. A., Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta 2007 1773 8 1263 1284 2-s2.0-34547209343 10.1016/j.bbamcr.2006.10.001 (Pubitemid 47125967)
11. McCubrey J. A., Steelman L. S., Abrams S. L., Lee J. T., Chang F., Bertrand F. E., Navolanic P. M., Terrian D. M., Franklin R. A., D'Assoro A. B., Salisbury J. L., Mazzarino M. C., Stivala F., Libra M., Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Advances in Enzyme Regulation 2006 46 1 249 279 2-s2.0-33748063941 10.1016/j.advenzreg.2006.01.004 (Pubitemid 44301348)
12. Kreisberg J. I., Malik S. N., Prihoda T. J., Bedolla R. G., Troyer D. A., Kreisberg S., Ghosh P. M., Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Research 2004 64 15 5232 5236 2-s2.0-3442891477 10.1158/0008-5472.CAN-04-0272 (Pubitemid 39006542)
13. Tanaka Y., Gavrielides M. V., Mitsuuchi Y., Fujii T., Kazanietz M. G., Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. Journal of Biological Chemistry 2003 278 36 33753 33762 2-s2.0-0141594871 10.1074/jbc.M303313200 (Pubitemid 37553209)
14. Robinson-White A., Stratakis C. A., Protein kinase a signaling: Cross-talk with other pathways in endocrine cells. Annals of the New York Academy of Sciences 2002 968 256 270 2-s2.0-0036293732 (Pubitemid 34721885)
15. Cui Q., So K. F., Involvement of cAMP in neuronal survival and axonal regeneration. Anatomical Science International 2004 79 4 209 212 2-s2.0-10944220829 (Pubitemid 40017306)
16. Kim Y., Seger R., Suresh Babu C. V., Hwang S. Y., Yoo Y. S., A positive role of the PI3-K/Akt signaling pathway in PC12 cell differentiation. Molecules and Cells 2004 18 3 353 359 2-s2.0-14544300519 (Pubitemid 40298032)
17. Nijholt I. M., Dolga A. M., Ostroveanu A., Luiten P. G. M., Schmidt M., Eisel U. L. M., Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation. Cellular Signalling 2008 20 10 1715 1724 2-s2.0-49549107515 10.1016/j.cellsig.2008.05.001
18. Millward T. A., Zolnierowicz S., Hemmings B. A., Regulation of protein kinase cascades by protein phosphatase 2A. Trends in Biochemical Sciences 1999 24 5 186 191 2-s2.0-0000714961 10.1016/S0968-0004(99)01375-4 (Pubitemid 29348452)
19. Yuan T. L., Cantley L. C., PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008 27 41 5497 5510 2-s2.0-51849111556 10.1038/onc.2008.245
20. Cully M., You H., Levine A. J., Mak T. W., Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature Reviews Cancer 2006 6 3 184 192 2-s2.0-33644513730 10.1038/nrc1819 (Pubitemid 43292562)
21. Lemmon D., Shiang T. Y., Hashmi A., Ulbrecht J. S., Cavanagh P. R., The effect of insoles in therapeutic footwear-a finite element approach. Journal of Biomechanics 1997 30 6 615 620 2-s2.0-0031172767 10.1016/S0021-9290(97)00006-7 (Pubitemid 27214193)
22. Alessi D. R., James S. R., Downes C. P., Holmes A. B., Gaffney P. R. J., Reese C. B., Cohen P., Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B α Current Biology 1997 7 4 261 269 2-s2.0-0031127305 (Pubitemid 27176852)
23. Sarbassov D. D., Guertin D. A., Ali S. M., Sabatini D. M., Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005 307 5712 1098 1101 2-s2.0-13844312400 10.1126/science.1106148 (Pubitemid 40262113)
24. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., Yan H., Gazdar A., Powell S. M., Riggins G. J., Willson J. K. V., Markowitz S., Kinzler K. W., Vogelstein B., Velculescu V. E., High frequency of mutations of the PIK3CA gene in human cancers. Science 2004 304 5670 554 2-s2.0-11144358645 10.1126/science.1096502 (Pubitemid 38541907)
25. Franke T. F., PI3K/Akt: getting it right matters. Oncogene 2008 27 50 6473 6488 2-s2.0-54949109808 10.1038/onc.2008.313
26. Chalhoub N., Baker S. J., PTEN and the PI3-kinase pathway in cancer. Annual Review of Pathology 2009 4 127 150 2-s2.0-66149141021 10.1146/annurev.pathol.4.110807.092311
27. Eichhorn P. J. A., Creyghton M. P., Bernards R., Protein phosphatase 2A regulatory subunits and cancer. Biochimica et Biophysica Acta 2009 1795 1 1 15 2-s2.0-58049186804 10.1016/j.bbcan.2008.05.005
28. Griner E. M., Kazanietz M. G., Protein kinase C and other diacylglycerol effectors in cancer. Nature Reviews Cancer 2007 7 4 281 294 2-s2.0-33947603008 10.1038/nrc2110 (Pubitemid 46480971)
29. Pearce L. R., Komander D., Alessi D. R., The nuts and bolts of AGC protein kinases. Nature Reviews Molecular Cell Biology 2010 11 1 9 22 2-s2.0-72949093349 10.1038/nrm2822
30. Chou M. M., Hou W., Johnson J., Graham L. K., Lee M. H., Chen C. S., Newton A. C., Schaffhausen B. S., Toker A., Regulation of protein kinase C ζ by PI 3-kinase and PDK-1. Current Biology 1998 8 19 1069 1077 2-s2.0-0032563936 (Pubitemid 28451031)
31. Dutil E. M., Toker A., Newton A. C., Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Current Biology 1998 8 25 1366 1375 2-s2.0-0032585532 (Pubitemid 29020145)
32. Facchinetti V., Ouyang W., Wei H., Soto N., Lazorchak A., Gould C., Lowry C., Newton A. C., Mao Y., Miao R. Q., Sessa W. C., Qin J., Zhang P., Su B., Jacinto E., The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO Journal 2008 27 14 1932 1943 2-s2.0-47949125486 10.1038/emboj.2008.120
33. Ikenoue T., Inoki K., Yang Q., Zhou X., Guan K. L., Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO Journal 2008 27 14 1919 1931 2-s2.0-47949104258 10.1038/emboj.2008.119
34. Kawakami Y., Nishimoto H., Kitaura J., Maeda-Yamamoto M., Kato R. M., Littman D. R., Rawlings D. J., Kawakami T., toshi@liai.org Protein kinase C β II regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. Journal of Biological Chemistry 2004 279 46 47720 47725 10.1074/jbc.M408797200 (Pubitemid 39540919)
35. Lu D., Huang J., Basu A., Protein kinase C ε activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor- α -induced cell death. Journal of Biological Chemistry 2006 281 32 22799 22807 2-s2.0-33747356750 10.1074/jbc.M603390200
36. Wu D., Peng F., Zhang B., Ingram A. J., Kelly D. J., Gilbert R. E., Gao B., Krepinsky J. C., PKC- β 1 mediates glucose-induced akt activation and TGF- β 1 upregulation in mesangial cells. Journal of the American Society of Nephrology 2009 20 3 554 566 2-s2.0-62149150630 10.1681/ASN.2008040445
37. Aeder S. E., Martin P. M., Soh J. W., Hussaini I. M., PKC- η mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. Oncogene 2004 23 56 9062 9069 2-s2.0-10944258108 10.1038/sj.onc.1208093 (Pubitemid 40013073)
38. Zhang D., Kanthasamy A., Yang Y., Anantharam V., Kanthasamy A., Protein kinase C δ negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. Journal of Neuroscience 2007 27 20 5349 5362 2-s2.0-34249006580 10.1523/JNEUROSCI.4107-06.2007 (Pubitemid 46790158)
39. Guan L., Song K., Pysz M. A., Curry K. J., Hizli A. A., Danielpour D., Black A. R., Black J. D., Protein kinase C-mediated down-regulation of cyclin D1 involves activation of the translational repressor 4E-BP1 via a phosphoinositide 3-kinase/Akt-independent, protein phosphatase 2A-dependent mechanism in intestinal epithelial cells. Journal of Biological Chemistry 2007 282 19 14213 14225 2-s2.0-34250635347 10.1074/jbc.M610513200 (Pubitemid 47100475)
40. Arciuch V. G. A., Alippe Y., Carreras M. C., Poderoso J. J., Mitochondrial kinases in cell signaling: facts and perspectives. Advanced Drug Delivery Reviews 2009 61 14 1234 1249 2-s2.0-71549160788 10.1016/j.addr.2009.04. 025
41. Zehorai E., Yao Z., Plotnikov A., Seger R., The subcellular localization of MEK and ERK-a novel nuclear translocation signal (NTS) paves a way to the nucleus. Molecular and Cellular Endocrinology 2010 314 2 213 220 2-s2.0-71849119627 10.1016/j.mce.2009.04.008
42. Feliciello A., Gottesman M. E., Avvedimento E. V., The biological functions of A-kinase anchor proteins. Journal of Molecular Biology 2001 308 2 99 114 2-s2.0-0035957525 10.1006/jmbi.2001.4585 (Pubitemid 33043558)
43. Alto N., Carlisle Michel J. J., Dodge K. L., Langeberg L. K., Scott J. D., Intracellular targeting of protein kinases and phosphatases. Diabetes 2002 51 3 S385 S388 2-s2.0-0036897218 (Pubitemid 35403421)
44. Dell'Acqua M. L., Smith K. E., Gorski J. A., Horne E. A., Gibson E. S., Gomez L. L., Regulation of neuronal PKA signaling through AKAP targeting dynamics. European Journal of Cell Biology 2006 85 7 627 633 2-s2.0-33744973573 10.1016/j.ejcb.2006.01.010 (Pubitemid 43863036)
45. Manning B. D., Cantley L. C., AKT/PKB signaling: navigating downstream. Cell 2007 129 7 1261 1274 2-s2.0-34250788809 10.1016/j.cell.2007.06.009 (Pubitemid 46962095)
46. Shepherd P. R., Withers D. J., Siddle K., Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochemical Journal 1998 333 3 471 490 2-s2.0-0032143284 (Pubitemid 28398511)
47. Lawlor M. A., Alessi D. R., PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? Journal of Cell Science 2001 114 16 2903 2910 2-s2.0-0034845958 (Pubitemid 32821530)
48. Lietzke S. E., Bose S., Cronin T., Klarlund J., Chawla A., Czech M. P., Lambright D. G., Structural basis of 3-phosphoinositide recognition by Pleckstrin homology domains. Molecular Cell 2000 6 2 385 394 2-s2.0-0033634785
49. Frech M., Andjelkovic M., Ingley E., Reddy K. K., Falck J. R., Hemmings B. A., High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity. Journal of Biological Chemistry 1997 272 13 8474 8481 2-s2.0-0030991386 10.1074/jbc.272.13.8474 (Pubitemid 27147810)
50. Thomas C. C., Deak M., Alessi D. R., Van Aalten D. M. F., High-resolution structure of the pleckstrin homology domain of protein kinase B/Akt bound to phosphatidylinositol (3,4,5)-trisphosphate. Current Biology 2002 12 14 1256 1262 2-s2.0-0037162293 10.1016/S0960-9822(02)00972-7 (Pubitemid 34801176)
51. Nicholson K. M., Anderson N. G., The protein kinase B/Akt signalling pathway in human malignancy. Cellular Signalling 2002 14 5 381 395 2-s2.0-0036185848 10.1016/S0898-6568(01)00271-6 (Pubitemid 34214843)
52. Hanada M., Feng J., Hemmings B. A., Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochimica et Biophysica Acta 2004 1697 1-2 3 16 2-s2.0-1542328927 10.1016/j.bbapap.2003.11.009 (Pubitemid 38326757)
53. Alessi D. R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B. A., Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO Journal 1996 15 23 6541 6551 2-s2.0-0029804116 (Pubitemid 26413787)
54. Yang J., Cron P., Good V. M., Thompson V., Hemmings B. A., Barford D., Crystal structure of an activated Akt/Protein Kinase B ternary complex with GSK3-peptide and AMP-PNP. Nature Structural Biology 2002 9 12 940 944 2-s2.0-18744373865 10.1038/nsb870 (Pubitemid 35417064)
55. Yang J., Cron P., Thompson V., Good V. M., Hess D., Hemmings B. A., Barford D., Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Molecular Cell 2002 9 6 1227 1240 2-s2.0-0036295728 10.1016/S1097-2765(02)00550-6 (Pubitemid 34722302)
56. Balendran A., Casamayor A., Deak M., Paterson A., Gaffney P., Currie R., Downes C. P., Alessi D. R., PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Current Biology 1999 9 8 393 404 2-s2.0-0033594480 10.1016/S0960-9822(99)80186-9 (Pubitemid 29205782)
57. Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G. F., Holmes A. B., Gaffney P. R. J., Reese C. B., McCormick F., Tempst P., Coadwell J., Hawkins P. T., Prohtein kinase B kinases that mediate phosphatidylinositol 3,4,5- trisphosphate-dependent activation of protein kinase B. Science 1998 279 5351 710 714 2-s2.0-0032578999 10.1126/science.279.5351.710 (Pubitemid 28144551)
58. Sasaki K., Sato M., Umezawa Y., Fluorescent indicators for Akt/protein kinase B and dynamics of Akt activity visualized in living cells. Journal of Biological Chemistry 2003 278 33 30945 30951 2-s2.0-0042733215 10.1074/jbc.M212167200 (Pubitemid 36994606)
59. Franke T. F., Kaplan D. R., Cantley L. C., PI3K: downstream AKTion blocks apoptosis. Cell 1997 88 4 435 437 2-s2.0-0030907987 10.1016/S0092-8674(00) 81883-8 (Pubitemid 27154408)
60. Martelli A. M., Faenza I., Billi A. M., Manzoli L., Evangelisti C., Falà F., Cocco L., Intranuclear 3′-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis? Cellular Signalling 2006 18 8 1101 1107 2-s2.0-33646379862 10.1016/j.cellsig.2006.01.011 (Pubitemid 43674029)
61. Parcellier A., Tintignac L. A., Zhuravleva E., Hemmings B. A., PKB and the mitochondria: AKTing on apoptosis. Cellular Signalling 2008 20 1 21 30 2-s2.0-36249002916 10.1016/j.cellsig.2007.07.010 (Pubitemid 350138366)
62. Rena G., Guo S., Cichy S. C., Unterman T. G., Cohen P., Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. Journal of Biological Chemistry 1999 274 24 17179 17183 2-s2.0-0033546439 10.1074/jbc.274.24.17179 (Pubitemid 29275181)
63. Biggs W. H. III, Meisenhelder J., Hunter T., Cavenee W. K., Arden K. C., Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proceedings of the National Academy of Sciences of the United States of America 1999 96 13 7421 7426 2-s2.0-0033595011 10.1073/pnas.96.13.7421 (Pubitemid 29299677)
64. Trotman L. C., Alimonti A., Scaglioni P. P., Koutcher J. A., Cordon-Cardo C., Pandolfi P. P., Identification of a tumour suppressor network opposing nuclear Akt function. Nature 2006 441 7092 523 527 2-s2.0-33745316089 10.1038/nature04809 (Pubitemid 44050155)
65. Datta S. R., Dudek H., Xu T., Masters S., Haian F., Gotoh Y., Greenberg M. E., Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997 91 2 231 241 2-s2.0-0030702123 10.1016/S0092- 8674(00)80405-5 (Pubitemid 27456390)
66. Gardai S. J., Hildeman D. A., Frankel S. K., Whitlock B. B., Frasch S. C., Borregaard N., Marrack P., Bratton D. L., Henson P. M., Phosphorylation of Bax ser184 by Akt regulates its activity and apoptosis in neutrophils. Journal of Biological Chemistry 2004 279 20 21085 21095 2-s2.0-2442681877 10.1074/jbc.M400063200 (Pubitemid 38656511)
67. Cardone M. H., Roy N., Stennicke H. R., Salvesen G. S., Franke T. F., Stanbridge E., Frisch S., Reed J. C., Regulation of cell death protease caspase-9 by phosphorylation. Science 1998 282 5392 1318 1321 2-s2.0-0032515027 (Pubitemid 28524494)
68. Fujita E., Jinbo A., Matuzaki H., Konishi H., Kikkawa U., Momoi T., Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochemical and Biophysical Research Communications 1999 264 2 550 555 2-s2.0-0033595720 10.1006/bbrc.1999.1387 (Pubitemid 29516123)
69. Hu Y., Yao J., Liu Z., Liu X., Fu H., Ye K., Akt phosphorylates acinus and inhibits its proteolytic cleavage, preventing chromatin condensation. EMBO Journal 2005 24 20 3543 3554 2-s2.0-27144446343 10.1038/sj.emboj.7600823 (Pubitemid 41509362)
70. Cross D. A. E., Alessi D. R., Cohen P., Andjelkovich M., Hemmings B. A., Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995 378 6559 785 789 2-s2.0-0029587224 10.1038/378785a0 (Pubitemid 26004411)
71. Forde J. E., Dale T. C., Glycogen synthase kinase 3: a key regulator of cellular fate. Cellular and Molecular Life Sciences 2007 64 15 1930 1944 2-s2.0-34447626493 10.1007/s00018-007-7045-7 (Pubitemid 47094432)
72. Bijur G. N., Jope R. S., Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. Journal of Neurochemistry 2003 87 6 1427 1435 2-s2.0-0346434149 (Pubitemid 38020576)
73. Rossignol R., Gilkerson R., Aggeler R., Yamagata K., Remington S. J., Capaldi R. A., Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Research 2004 64 3 985 993 2-s2.0-0842325793 10.1158/0008-5472.CAN-03-1101 (Pubitemid 38176901)
74. Alvarez-Tejado M., Naranjo-Suárez S., Jiménez C., Carrera A. C., Landázuri M. O., Del Peso L., Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells. Protective role in apoptosis. Journal of Biological Chemistry 2001 276 25 22368 22374 2-s2.0-0035933726 10.1074/jbc.M011688200
75. Pelicano H., Xu R. H., Du M., Feng L., Sasaki R., Carew J. S., Hu Y., Ramdas L., Hu L., Keating M. J., Zhang W., Plunkett W., Huang P., Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. Journal of Cell Biology 2006 175 6 913 923 2-s2.0-33845718704 10.1083/jcb.200512100 (Pubitemid 44969197)
76. Gottlob K., Majewski N., Kennedy S., Kandel E., Robey R. B., Hay N., Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes and Development 2001 15 11 1406 1418 2-s2.0-0034983918 10.1101/gad.889901 (Pubitemid 32524647)
77. Robey R. B., Hay N., Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 2006 25 34 4683 4696 2-s2.0-33746927077 10.1038/sj.onc.1209595 (Pubitemid 44187618)
78. Azoulay-Zohar H., Israelson A., Abu-Hamad S., Shoshan-Barmatz V., In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochemical Journal 2004 377 2 347 355 2-s2.0-0942290437 10.1042/BJ20031465 (Pubitemid 38142190)
79. Zaid H., Abu-Hamad S., Israelson A., Nathan I., Shoshan-Barmatz V., The voltage-dependent anion channel-1 modulates apoptotic cell death. Cell Death and Differentiation 2005 12 7 751 760 2-s2.0-21744441655 10.1038/sj.cdd.4401599 (Pubitemid 40945982)
80. Khan M. T., Wagner L., Yule D. I., Bhanumathy C., Joseph S. K., Akt kinase phosphorylation of inositol 1,4,5-trisphosphate receptors. Journal of Biological Chemistry 2006 281 6 3731 3737 2-s2.0-33645642577 10.1074/jbc.M509262200 (Pubitemid 43845991)
81. Pinton P., Rizzuto R., Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum. Cell Death and Differentiation 2006 13 8 1409 1418 2-s2.0-33745958168 10.1038/sj.cdd.4401960 (Pubitemid 44057477)
82. Szado T., Vanderheyden V., Parys J. B., De Smedt H., Rietdorf K., Kotelevets L., Chastre E., Khan F., Landegren U., Söderberg O., Bootman M. D., Roderick H. L., Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 7 2427 2432 2-s2.0-40649096621 10.1073/pnas.0711324105 (Pubitemid 351520530)
83. Marchi S., Rimessi A., Giorgi C., Baldini C., Ferroni L., Rizzuto R., Pinton P., Akt kinase reducing endoplasmic reticulum Ca2+ release protects cells from Ca2+-dependent apoptotic stimuli. Biochemical and Biophysical Research Communications 2008 375 4 501 505 2-s2.0-51649083933 10.1016/j.bbrc.2008.07.153
84. Giorgi C., Ito K., Lin H. K., Santangelo C., Wieckowski M. R., Lebiedzinska M., Bononi A., Bonora M., Duszynski J., Bernardi R., Rizzuto R., Tacchetti C., Pinton P., Pandolfi P. P., PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 2010 330 6008 1247 1251 2-s2.0-78649425814 10.1126/science.1189157
85. Aslan J. E., You H., Williamson D. M., Endig J., Youker R. T., Thomas L., Shu H., Du Y., Milewski R. L., Brush M. H., Possemato A., Sprott K., Fu H., Greis K. D., Runckel D. N., Vogel A., Thomas G., Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis. Molecular Cell 2009 34 4 497 509 2-s2.0-65849216826 10.1016/j.molcel.2009.04.011
86. Scott P. H., Brunn G. J., Kohn A. D., Roth R. A., Lawrence J. C., Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proceedings of the National Academy of Sciences of the United States of America 1998 95 13 7772 7777 2-s2.0-0032560521 10.1073/pnas.95.13.7772 (Pubitemid 28293329)
87. Potter C. J., Pedraza L. G., Xu T., Akt regulates growth by directly phosphorylating Tsc2. Nature Cell Biology 2002 4 9 658 665 2-s2.0-0036714127 10.1038/ncb840 (Pubitemid 34993701)
88. Manning B. D., Cantley L. C., Rheb fills a GAP between TSC and TOR. Trends in Biochemical Sciences 2003 28 11 573 576 2-s2.0-0347716759 10.1016/j.tibs.2003.09.003 (Pubitemid 38352801)
89. Kovacina K. S., Park G. Y., Bae S. S., Guzzetta A. W., Schaefer E., Birnbaum M. J., Roth R. A., Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. Journal of Biological Chemistry 2003 278 12 10189 10194 2-s2.0-0037855834 10.1074/jbc.M210837200 (Pubitemid 36800278)
90. Haar E. V., Lee S. I., Bandhakavi S., Griffin T. J., Kim D. H., Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nature Cell Biology 2007 9 3 316 323 2-s2.0-33847397874 10.1038/ncb1547 (Pubitemid 46344611)
91. Skeen J. E., Bhaskar P. T., Chen C. C., Chen W. S., Peng X. D., Nogueira V., Hahn-Windgassen A., Kiyokawa H., Hay N., Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell 2006 10 4 269 280 2-s2.0-33749430399 10.1016/j.ccr.2006.08.022 (Pubitemid 44512190)
92. Rosen N., She Q. B., AKT and cancer-is it all mTOR? Cancer Cell 2006 10 4 254 256 2-s2.0-33749447286 10.1016/j.ccr.2006.10.001 (Pubitemid 44512196)
93. Dennis P. B., Jaeschke A., Saitoh M., Fowler B., Kozma S. C., Thomas G., Mammalian TOR: a homeostatic ATP sensor. Science 2001 294 5544 1102 1105 2-s2.0-0035798097 10.1126/science.1063518 (Pubitemid 33041865)
94. Murakami M., Ichisaka T., Maeda M., Oshiro N., Hara K., Edenhofer F., Kiyama H., Yonezawa K., Yamanaka S., mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Molecular and Cellular Biology 2004 24 15 6710 6718 2-s2.0-3242721268 10.1128/MCB.24.15.6710- 6718.2004 (Pubitemid 38944350)
95. Huang S., Houghton P. J., Targeting mTOR signaling for cancer therapy. Current Opinion in Pharmacology 2003 3 4 371 377 2-s2.0-0041802820 10.1016/S1471-4892(03)00071-7 (Pubitemid 36908940)
96. Janus A., Robak T., Smolewski P., The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy. Cellular and Molecular Biology Letters 2005 10 3 479 498 2-s2.0-27644447574 (Pubitemid 41564520)
97. Yang Q., Guan K. L., Expanding mTOR signaling. Cell Research 2007 17 8 666 681 2-s2.0-34547907805 10.1038/cr.2007.64 (Pubitemid 47255937)
98. Cutler C., Antin J. H., Giles F. J., Mammalian target of rapamycin inhibition as therapy for hematologic malignancies. Cancer 2004 101 6 1478 2-s2.0-4444258766 10.1002/cncr.20495 (Pubitemid 39180405)
99. Sengupta S., Peterson T. R., Sabatini D. M., Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Molecular Cell 2010 40 2 310 322 2-s2.0-78649348967 10.1016/j.molcel.2010.09.026
100. Rosner M., Hanneder M., Siegel N., Valli A., Fuchs C., Hengstschläger M., The mTOR pathway and its role in human genetic diseases. Mutation Research 2008 659 3 284 292 2-s2.0-49849090082 10.1016/j.mrrev.2008. 06.001
101. Pearce L. R., Huang X., Boudeau J., Pawowski R., Wullschleger S., Deak M., Ibrahim A. F. M., Gourlay R., Magnuson M. A., Alessi D. R., Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochemical Journal 2007 405 3 513 522 2-s2.0-34347210090 10.1042/BJ20070540 (Pubitemid 47172049)
102. García-Martínez J. M., Alessi D. R., mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochemical Journal 2008 416 3 375 385 2-s2.0-58649092475 10.1042/BJ20081668
103. Guertin D. A., Stevens D. M., Thoreen C. C., Burds A. A., Kalaany N. Y., Moffat J., Brown M., Fitzgerald K. J., Sabatini D. M., Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Developmental Cell 2006 11 6 859 871 2-s2.0-33751348056 10.1016/j.devcel.2006.10.007 (Pubitemid 44804279)
104. Shatkin A. J., mRNA cap binding proteins: essential factors for initiating translation. Cell 1985 40 2 223 224 2-s2.0-0021921587 (Pubitemid 15138450)
105. Pause A., Belsham G. J., Gingras A. C., Donze O., Lin T. A., Lawrence J. C., Sonenberg N., Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature 1994 371 6500 762 767 2-s2.0-0028034233 10.1038/371762a0 (Pubitemid 24333862)
106. Beretta L., Gingras A. C., Svitkin Y. V., Hall M. N., Sonenberg N., Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO Journal 1996 15 3 658 664 2-s2.0-0030066934 (Pubitemid 26044579)
107. Price D. J., Grove J. R., Calvo V., Avruch J., Bierer B. E., Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 1992 257 5072 973 977 2-s2.0-0026759874
108. Tsang C. K., Liu H., Zheng X. F. S., mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes. Cell Cycle 2010 9 5 953 957 2-s2.0-77953512889
109. Hannan K. M., Brandenburger Y., Jenkins A., Sharkey K., Cavanaugh A., Rothblum L., Moss T., Poortinga G., McArthur G. A., Pearson R. B., Hannan R. D., mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Molecular and Cellular Biology 2003 23 23 8862 8877 2-s2.0-0242637318 10.1128/MCB.23.23.8862-8877.2003 (Pubitemid 37433385)
110. Mayer C., Grummt I., Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 2006 25 48 6384 6391 2-s2.0-33750044901 10.1038/sj.onc.1209883 (Pubitemid 44582283)
111. Mayer C., Zhao J., Yuan X., Grummt I., mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes and Development 2004 18 4 423 434 2-s2.0-1542343973 10.1101/gad.285504 (Pubitemid 38316349)
112. Matsuo M., Yamada S., Koizumi K., Sakurai H., Saiki I., Tumour-derived fibroblast growth factor-2 exerts lymphangiogenic effects through Akt/mTOR/p70S6kinase pathway in rat lymphatic endothelial cells. European Journal of Cancer 2007 43 11 1748 1754 2-s2.0-34447257690 10.1016/j.ejca.2007. 04.024 (Pubitemid 47042372)
113. Ma L., Chen Z., Erdjument-Bromage H., Tempst P., Pandolfi P. P., Phosphorylation and functional inactivation of TSC2 by Erk: implications for tuberous sclerosis and cancer pathogenesis. Cell 2005 121 2 179 193 2-s2.0-17444431201 10.1016/j.cell.2005.02.031 (Pubitemid 40546387)
114. Wouters B. G., Koritzinsky M., Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nature Reviews Cancer 2008 8 11 851 864 2-s2.0-54549089738 10.1038/nrc2501
115. Semenza G. L., Hif-1 and human disease: one highly involved factor. Genes and Development 2000 14 16 1983 1991 2-s2.0-0034663989 (Pubitemid 30637348)
116. Düvel K., Yecies J. L., Menon S., Raman P., Lipovsky A. I., Souza A. L., Triantafellow E., Ma Q., Gorski R., Cleaver S., Vander Heiden M. G., MacKeigan J. P., Finan P. M., Clish C. B., Murphy L. O., Manning B. D., Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular Cell 2010 39 2 171 183 2-s2.0-77955483125 10.1016/j.molcel.2010.06.022
117. Laughner E., Taghavi P., Chiles K., Mahon P. C., Semenza G. L., HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1 α (HIF-1 α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Molecular and Cellular Biology 2001 21 12 3995 4004 2-s2.0-0035012605 10.1128/MCB.21.12.3995-4004.2001 (Pubitemid 32476461)
118. Thomas G. V., Tran C., Mellinghoff I. K., Welsbie D. S., Chan E., Fueger B., Czernin J., Sawyers C. L., Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nature Medicine 2006 12 1 122 127 2-s2.0-30044432434 10.1038/nm1337 (Pubitemid 43050086)
119. Sofer A., Lei K., Johannessen C. M., Ellisen L. W., Regulation of mTOR and cell growth in response to energy stress by REDD1. Molecular and Cellular Biology 2005 25 14 5834 5845 2-s2.0-21744459535 10.1128/MCB.25.14.5834-5845.2005 (Pubitemid 40946541)
120. Ravikumar B., Sarkar S., Davies J. E., Futter M., Garcia-Arencibia M., Green-Thompson Z. W., Jimenez-Sanchez M., Korolchuk V. I., Lichtenberg M., Luo S., Massey D. C. O., Menzies F. M., Moreau K., Narayanan U., Renna M., Siddiqi F. H., Underwood B. R., Winslow And A. R., Rubinsztein D. C., Regulation of mammalian autophagy in physiology and pathophysiology. Physiological Reviews 2010 90 4 1383 1435 2-s2.0-78149475088 10.1152/physrev.00030.2009
121. Mizushima N., The role of the Atg1/ULK1 complex in autophagy regulation. Current Opinion in Cell Biology 2010 22 2 132 139 2-s2.0-77951221542 10.1016/j.ceb.2009.12.004
122. Desai B. N., Myers B. R., Schreiber S. L., FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proceedings of the National Academy of Sciences of the United States of America 2002 99 7 4319 4324 2-s2.0-0037007014 10.1073/pnas.261702698 (Pubitemid 34285983)
123. Kim J. E., Chen J., Cytoplasmic-nuclear shuttling of FKBP12-rapamycin- associated protein is involved in rapamycin-sensitive signaling and translation initiation. Proceedings of the National Academy of Sciences of the United States of America 2000 97 26 14340 14345 2-s2.0-0034687688 10.1073/pnas.011511898 (Pubitemid 32016577)
124. Zhang X., Shu L., Hosoi H., Gopal Murti K., Houghton P. J., Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture. Journal of Biological Chemistry 2002 277 31 28127 28134 2-s2.0-0037008730 10.1074/jbc.M202625200 (Pubitemid 34966765)
125. Drenan R. M., Liu X., Bertram P. G., Zheng X. F. S., FKBP12-rapamycin- associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus. Journal of Biological Chemistry 2004 279 1 772 778 2-s2.0-0346422440 10.1074/jbc.M305912200 (Pubitemid 38044883)
126. Liu X., Zheng X. F. S., Endoplasmic reticulum and Golgi localization sequences for mammalian target of rapamycin. Molecular Biology of the Cell 2007 18 3 1073 1082 2-s2.0-33947145667 10.1091/mbc.E06-05-0406 (Pubitemid 46399510)
127. Wlodkowic D., Skommer J., McGuinness D., Hillier C., Darzynkiewicz Z.,
128. Sancak Y., Peterson T. R., Shaul Y. D., Lindquist R. A., Thoreen C. C., Bar-Peled L., Sabatini D. M., The rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008 320 5882 1496 1501 2-s2.0-45849105156 10.1126/science.1157535 (Pubitemid 351929429)
129. Sancak Y., Bar-Peled L., Zoncu R., Markhard A. L., Nada S., Sabatini D. M., Ragulator-rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010 141 2 290 303 2-s2.0-77951768486 10.1016/j.cell.2010.02.024
130. Schieke S. M., Phillips D., McCoy J. P. Jr., Aponte A. M., Shen R. F., Balaban R. S., Finkel T., The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. Journal of Biological Chemistry 2006 281 37 27643 27652 2-s2.0-33748752151 10.1074/jbc.M603536200 (Pubitemid 44401789)
131. Cunningham J. T., Rodgers J. T., Arlow D. H., Vazquez F., Mootha V. K., Puigserver P., mTOR controls mitochondrial oxidative function through a YY1-PGC-1 α transcriptional complex. Nature 2007 450 7170 736 740 2-s2.0-36749081539 10.1038/nature06322 (Pubitemid 350207689)
132. Bai X., Ma D., Liu A., Shen X., Wang Q. J., Liu Y., Jiang Y., Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science 2007 318 5852 977 980 2-s2.0-36049043184 10.1126/science.1147379 (Pubitemid 350098994)
133. Ramanathan A., Schreiber S. L., Direct control of mitochondrial function by mTOR. Proceedings of the National Academy of Sciences of the United States of America 2009 106 52 22229 22232 2-s2.0-76049099052 10.1073/pnas.0912074106
134. Vezina C., Kudelski A., Sehgal S. N., Rapamycin (AY 22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. Journal of Antibiotics 1975 28 10 721 726 2-s2.0-0016724057
135. Um S. H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P. R., Kozma S. C., Auwerx J., Thomas G., Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004 431 7005 200 205 2-s2.0-4544220704 10.1038/nature02866 (Pubitemid 39243474)
136. Feldman M. E., Apsel B., Uotila A., Loewith R., Knight Z. A., Ruggero D., Shokat K. M., Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biology 2009 7 2 e1000038 2-s2.0-61349141302 10.1371/journal.pbio.1000038
137. Lechward K., Awotunde O. S., Swiatek W., Muszyska G., muszynsk@ibb.waw.pl Protein phosphatase 2A: variety of forms and diversity of functions. Acta Biochimica Polonica 2001 48 4 921 933 (Pubitemid 33602348)
138. Van Hoof C., Goris J., Jozef.Goris@med.kuleuven.ac.be Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question. Biochimica et Biophysica Acta 2003 1640 2-3 97 104 10.1016/S0167-4889(03)00029-6 (Pubitemid 36555695)
139. Yang J., Phiel C., Functions of B56-containing PP2As in major developmental and cancer signaling pathways. Life Sciences 2010 87 23-26 659 666 2-s2.0-78649448708 10.1016/j.lfs.2010.10.003
140. Shi Y., Serine/threonine phosphatases: mechanism through structure. Cell 2009 139 3 468 484 2-s2.0-70350340056 10.1016/j.cell.2009.10.006
141. Janssens V., Longin S., Goris J., PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends in Biochemical Sciences 2008 33 3 113 121 2-s2.0-39949083195 10.1016/j.tibs.2007.12.004
142. Forester C. M., Maddox J., Louis J. V., Goris J., Virshup D. M., Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1. Proceedings of the National Academy of Sciences of the United States of America 2007 104 50 19867 19872 2-s2.0-38049165541 10.1073/pnas.0709879104
143. Flegg C. P., Sharma M., Medina-Palazon C., Jamieson C., Galea M., Brocardo M. G., Mills K., Henderson B. R., Nuclear export and centrosome targeting of the protein phosphatase 2A subunit B56 α: role of B56 α in nuclear export of the catalytic subunit. Journal of Biological Chemistry 2010 285 24 18144 18154 2-s2.0-77953300022 10.1074/jbc.M109.093294
144. Jin Z., Shi J., Saraf A., Mei W., Zhu G. Z., Strack S., Yang J., The 48-kDa alternative translation isoform of PP2A:B56 ε is required for Wnt signaling during midbrain-hindbrain boundary formation. Journal of Biological Chemistry 2009 284 11 7190 7200 2-s2.0-65449139556 10.1074/jbc.M807907200
145. Riedel C. G., Katis V. L., Katou Y., Mori S., Itoh T., Helmhart W., Gálová M., Petronczki M., Gregan J., Cetin B., Mudrak I., Ogris E., Mechtler K., Pelletier L., Buchholz F., Shirahige K., Nasmyth K., Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I. Nature 2006 441 1 53 61 2-s2.0-33646819227 10.1038/nature04664
146. Xu Z., Cetin B., Anger M., Cho U. S., Helmhart W., Nasmyth K., Xu W., Structure and function of the PP2A-shugoshin interaction. Molecular Cell 2009 35 4 426 441 2-s2.0-68949206308 10.1016/j.molcel.2009.06.031
147. Ito A., Kataoka T. R., Watanabe M., Nishiyama K., Mazaki Y., Sabe H., Kitamura Y., Nojima H., A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation. EMBO Journal 2000 19 4 562 571 2-s2.0-0034651747 (Pubitemid 30093729)
148. Ruvolo P. P., Deng X., Ito T., Carr B. K., May W. S., Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. Journal of Biological Chemistry 1999 274 29 20296 20300 2-s2.0-0033575320 10.1074/jbc.274.29.20296 (Pubitemid 29340382)
149. Ruvolo P. P., Clark W., Mumby M., Gao F., Stratford May W., A functional role for the B56 α -subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. Journal of Biological Chemistry 2002 277 25 22847 22852 2-s2.0-0037151038 10.1074/jbc.M201830200 (Pubitemid 34967266)
150. Perrotti D., Neviani P., Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias. Cancer and Metastasis Reviews 2008 27 2 159 168 2-s2.0-43049112747 10.1007/s10555-008-9119-x
151. Janssens V., Goris J., Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochemical Journal 2001 353 3 417 439 2-s2.0-0035252894 10.1042/0264-6021: 3530417 (Pubitemid 32158309)
152. Chen J., Martin B. L., Brautigan D. L., Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 1992 257 5074 1261 1264 2-s2.0-0026786471
153. Westermarck J., Hahn W. C., Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends in Molecular Medicine 2008 14 4 152 160 2-s2.0-41549090369 10.1016/j.molmed.2008.02.001
154. Sontag E., Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cellular Signalling 2001 13 1 7 16 2-s2.0-0035100658 10.1016/S0898-6568(00)00123-6 (Pubitemid 32222967)
155. Liao Y., yongliao@mdanderson.org Hung M.-C., mhung@mdanderson.org Physiological regulation of Akt activity and stability. American Journal of Translational Research 2010 2 1 19 42
156. Mochida S., Maslen S. L., Skehel M., Hunt T., Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science 2010 330 6011 1670 1673 2-s2.0-78650366525 10.1126/science.1195689
157. Marx S. O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., Marks A. R., PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000 101 4 365 376 2-s2.0-0034640113
158. Lee T. Y., Lai T. Y., Lin S. C., Wu C. W., Ni I. F., Yang Y. S., Hung L. Y., Law B. K., Chiang C. W., The B56 γ 3 regulatory subunit of protein phosphatase 2A (PP2A) regulates S phase-specific nuclear accumulation of PP2A and the G1 to S transition. Journal of Biological Chemistry 2010 285 28 21567 21580 2-s2.0-77954367131 10.1074/jbc.M109.094953
159. Manchado E., Guillamot M., de Cárcer G., Eguren M., Trickey M., García-Higuera I., Moreno S., Yamano H., Caamero M., Malumbres M., malumbres@cnio.es Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A/B55 α δ phosphatase. Cancer Cell 2010 18 6 641 654 10.1016/j.ccr.2010.10.028
160. Potapova T. A., tpo@stowers.org Sivakumar S., Flynn J. N., Li R., Gorbsky G. J., Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited. Molecular Biology of the Cell 2011 22 8 1191 1206 10.1091/mbc.E10-07-0599
161. Gharbi-Ayachi A., Labbé J. C., Burgess A., Vigneron S., Strub J. M., Brioudes E., Van-Dorsselaer A., Castro A., Lorca T., The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science 2010 330 6011 1673 1677 2-s2.0-78650381938 10.1126/science.1197048
162. Aggarwal S., Suzuki T., Taylor W. L., Bhargava A., Rao R. K., rrao2 uthsc.edu Contrasting effects of ERK on tight junction integrity in differentiated and under-differentiated Caco-2 cell monolayers. Biochemical Journal 2011 433 1 51 63 10.1042/BJ20100249
163. Li Y., Yue P., Deng X., Ueda T., Fukunaga R., Khuri F. R., Sun S. Y., Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eif4F assembly through direct dephosphorylation of mnk and eif4E. Neoplasia 2010 12 10 848 855 2-s2.0-77957765231 10.1593/neo.10704
164. Okamoto K., Li H., Jensen M. R., Zhang T., Taya Y., Thorgeirsson S. S., Prives C., Cyclin G recruits PP2A to dephosphorylate Mdm2. Molecular Cell 2002 9 4 761 771 2-s2.0-0036235121 10.1016/S1097-2765(02)00504-X (Pubitemid 34454888)
165. Kray A. E., Carter R. S., Pennington K. N., Gomez R. J., Sanders L. E., Llanes J. M., Khan W. N., Ballard D. W., Wadzinski B. E., Positive regulation of I κ B kinase signaling by protein serine/threonine phosphatase 2A. Journal of Biological Chemistry 2005 280 43 35974 35982 2-s2.0-27744553677 10.1074/jbc.M506093200 (Pubitemid 41633866)
166. Sablina A. A., Hahn W. C., The role of PP2A A subunits in tumor suppression. Cell adhesion & migration 2007 1 3 140 141 2-s2.0-66549085133
167. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S. H., Giovanella B. C., Ittmann M., Tycko B., Hibshoosh H., Wigler M. H., Parsons R., PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997 275 5308 1943 1947 2-s2.0-0030936323 10.1126/science.275.5308.1943 (Pubitemid 27148818)
168. Steck P. A., Pershouse M. A., Jasser S. A., Yung W. K. A., Lin H., Ligon A. H., Langford L. A., Baumgard M. L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D. H. F., Tavtigian S. V., Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics 1997 15 4 356 362 2-s2.0-17144436629 10.1038/ng0497-356 (Pubitemid 27147102)
169. Li D. M., Sun H., TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β Cancer Research 1997 57 11 2124 2129 2-s2.0-0031001041 (Pubitemid 27247025)
170. Simpson L., Parsons R., PTEN: life as a tumor suppressor. Experimental Cell Research 2001 264 1 29 41 2-s2.0-0035835824 10.1006/excr.2000.5130 (Pubitemid 32989079)
171. Keniry M., Parsons R., The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 2008 27 41 5477 5485 2-s2.0-51849097348 10.1038/onc.2008.248
172. Hobert J. A., Eng C., PTEN hamartoma tumor syndrome: an overview. Genetics in Medicine 2009 11 10 687 694 2-s2.0-70350238781 10.1097/GIM. 0b013e3181ac9aea
173. Butler M. G., Dazouki M. J., Zhou X. P., Talebizadeh Z., Brown M., Takahashi T. N., Miles J. H., Wang C. H., Stratton R., Pilarski R., Eng C., Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Journal of Medical Genetics 2005 42 4 318 321 2-s2.0-20244367771 10.1136/jmg.2004.024646 (Pubitemid 40523954)
174. Nardella C., Carracedo A., Salmena L., Pandolfi P. P., Faithfull modeling of PTEN loss driven diseases in the mouse. Current topics in Microbiology and Immunology 2010 347 135 168
175. Carracedo A., Alimonti A., Pandolfi P. P., ppandolf@bidmc.harvard.edu PTEN level in tumor suppression: how much is too little? Cancer Research 2011 71 3 629 633 10.1158/0008-5472.CAN-10-2488
176. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P. P., Pten is essential for embryonic development and tumour suppression. Nature Genetics 1998 19 4 348 355 2-s2.0-0031870959 10.1038/1235 (Pubitemid 28357906)
177. Suzuki A., De La Pompa J. L., Stambolic V., Elia A. J., Sasaki T., Del Barco Barrantes I., Ho A., Wakeham A., Itie A., Khoo W., Fukumoto M., Mak T. W., High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Current Biology 1998 8 21 1169 1178 2-s2.0-13144249184 (Pubitemid 28494715)
178. Podsypanina K., Ellenson L. H., Nemes A., Gu J., Tamura M., Yamada K. M., Cordon-Cardo C., Catoretti G., Fisher P. E., Parsons R., Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proceedings of the National Academy of Sciences of the United States of America 1999 96 4 1563 1568 2-s2.0-13044250465 10.1073/pnas.96.4.1563 (Pubitemid 29098491)
179. Trotman L. C., Niki M., Dotan Z. A., Koutcher J. A., Di Cristofano A., Xiao A., Khoo A. S., Roy-Burman P., Greenberg N. M., Van Dyke T., Cordon-Cardo C., Pandolfi P. P., Pten dose dictates cancer progression in the prostate. PLoS Biology 2003 1 3, article E59 2-s2.0-4243110417 10.1371/journal.pbio.0000059 (Pubitemid 39112137)
180. Wang S., Gao J., Lei Q., Rozengurt N., Pritchard C., Jiao J., Thomas G. V., Li G., Roy-Burman P., Nelson P. S., Liu X., Wu H., Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 2003 4 3 209 221 2-s2.0-10744222860 10.1016/S1535-6108(03) 00215-0 (Pubitemid 37163835)
181. Maehama T., Dixon J. E., The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. Journal of Biological Chemistry 1998 273 22 13375 13378 2-s2.0-0032577699 10.1074/jbc.273.22.13375 (Pubitemid 28268370)
182. Myers M. P., Pass I., Batty I. H., Van Der Kaay J., Stolarov J. P., Hemmings B. A., Wigler M. H., Downes C. P., Tonks N. K., The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proceedings of the National Academy of Sciences of the United States of America 1998 95 23 13513 13518 2-s2.0-0032506011 10.1073/pnas.95.23.13513 (Pubitemid 28523003)
183. Liu Y., Bankaitis V. A., Phosphoinositide phosphatases in cell biology and disease. Progress in Lipid Research 2010 49 3 201 217 2-s2.0-77952107210 10.1016/j.plipres.2009.12.001
184. Leslie N. R., Maccario H., Spinelli L., Davidson L., The significance of PTEN's protein phosphatase activity. Advances in Enzyme Regulation 2009 49 1 190 196 2-s2.0-66449102220 10.1016/j.advenzreg.2008.12.002
185. Myers M. P., Stolarov J. P., Eng C., Li J., Wang S. I., Wigler M. H., Parsons R., Tonks N. K., P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proceedings of the National Academy of Sciences of the United States of America 1997 94 17 9052 9057 2-s2.0-0030837555
186. Tamura M., Gu J., Matsumoto K., Aota S. I., Parsons R., Yamada K. M., Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998 280 5369 1614 1617 2-s2.0-0032486198 10.1126/science.280. 5369.1614 (Pubitemid 28277707)
187. Dey N., Crosswell H. E., Pradip D., Parsons R., Peng Q., Jing D. S., Durden D. L., The protein phosphatase activity of PTEN regulates Src family kinases and controls glioma migration. Cancer Research 2008 68 6 1862 1871 2-s2.0-40949099624 10.1158/0008-5472.CAN-07-1182 (Pubitemid 351416572)
188. Leslie N. R., Yang X., Downes C. P., Weijer C. J., The regulation of cell migration by PTEN. Biochemical Society Transactions 2005 33 6 1507 1508 2-s2.0-28844467594 10.1042/BST20051507 (Pubitemid 41779725)
189. Raftopoulou M., Etienne-Manneville S., Self A., Nicholls S., Hall A., Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 2004 303 5661 1179 1181 2-s2.0-1242284600 10.1126/science.1092089 (Pubitemid 38233580)
190. Mahimainathan L., Ghosh Choudhury G., Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. Journal of Biological Chemistry 2004 279 15 15258 15268 2-s2.0-2442498583 10.1074/jbc.M314328200 (Pubitemid 38618922)
191. Weng L. P., Brown J. L., Baker K. M., Ostrowski M. C., Eng C., PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Human Molecular Genetics 2002 11 15 1687 1696 2-s2.0-0037098951 (Pubitemid 34812090)
192. Weng L. P., Brown J. L., Eng C., PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase acitvity in a breast cancer model. Human Molecular Genetics 2001 10 6 599 604 2-s2.0-0035869212 (Pubitemid 32229364)
193. Stambolic V., Suzuki A., De la Pompa J. L., Brothers G. M., Mirtsos C., Sasaki T., Ruland J., Penninger J. M., Siderovski D. P., Mak T. W., Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998 95 1 29 39 2-s2.0-0032475861 10.1016/S0092-8674(00)81780-8 (Pubitemid 28458022)
194. Haas-Kogan D., Shalev N., Wong M., Mills G., Yount G., Stokoe D., Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Current Biology 1998 8 21 1195 1198 2-s2.0-0032558822 (Pubitemid 28494720)
195. Poliseno L., Salmena L., Zhang J., Carver B., Haveman W. J., Pandolfi P. P., A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010 465 7301 1033 1038 2-s2.0-77953957633 10.1038/nature09144
196. Salmena L., Carracedo A., Pandolfi P. P., Tenets of PTEN Tumor Suppression. Cell 2008 133 3 403 414 2-s2.0-43049128529 10.1016/j.cell.2008.04. 013 (Pubitemid 351622014)
197. Leslie N. R., n.r.leslie@dundee.ac.uk Foti M., Non-genomic loss of PTEN function in cancer: not in my genes. Trends in Pharmacological Sciences 2011 32 3 131 140 10.1016/j.tips.2010.12.005
198. Tamguney T., Stokoe D., New insights into PTEN. Journal of Cell Science 2007 120 23 4071 4079 2-s2.0-38349030742 10.1242/jcs.015230
199. Eng C., eng-1@medctr.osu.edu PTEN: one gene, Many syndromes. Human Mutation 2003 22 3 183 198 10.1002/humu.10257 (Pubitemid 37071635)
200. Lee J. O., Yang H., Georgescu M. M., Cristofano A. D., Maehama T., Shi Y., Dixon J. E., Pandolfi P., Pavletich N. P., Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 1999 99 3 323 334 2-s2.0-0033615538 10.1016/S0092-8674(00)81663-3 (Pubitemid 29519911)
201. Gericke A., Munson M., Ross A. H., Regulation of the PTEN phosphatase. Gene 2006 374 1-2 1 9 2-s2.0-33646705667 10.1016/j.gene.2006.02.024 (Pubitemid 43737118)
202. Georgescu M. M., Kirsch K. H., Kaloudis P., Yang H., Pavletich N. P., Hanafusa H., Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Research 2000 60 24 7033 7038 2-s2.0-0034671221 (Pubitemid 32059181)
203. Vazquez F., Devreotes P., Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction. Cell Cycle 2006 5 14 1523 1527 2-s2.0-33746225428 (Pubitemid 44091972)
204. Torres J., Pulido R., The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. Journal of Biological Chemistry 2001 276 2 993 998 2-s2.0-0035847102 10.1074/jbc.M009134200 (Pubitemid 32096519)
205. Maccario H., Perera N. M., Davidson L., Downes C. P., Leslie N. R., PTEN is destabilized by phosphorylation on Thr366. Biochemical Journal 2007 405 3 439 444 2-s2.0-34547490078 10.1042/BJ20061837 (Pubitemid 47172040)
206. Okahara F., Ikawa H., Kanaho Y., Maehama T., Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. Journal of Biological Chemistry 2004 279 44 45300 45303 2-s2.0-8544256358 10.1074/jbc.C400377200 (Pubitemid 39491510)
207. Vemula S., Shi J., Hanneman P., Wei L., Kapur R., ROCK1 functions as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Blood 2010 115 9 1785 1796 2-s2.0-77950365395 10.1182/blood-2009-08- 237222
208. Vazquez F., Ramaswamy S., Nakamura N., Sellers W. R., Phosphorylation of the PTEN tail regulates protein stability and function. Molecular and Cellular Biology 2000 20 14 5010 5018 2-s2.0-0033946740 10.1128/MCB.20.14.5010-5018.2000 (Pubitemid 30431555)
209. Vazquez F., Grossman S. R., Takahashi Y., Rokas M. V., Nakamura N., Sellers W. R., Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. Journal of Biological Chemistry 2001 276 52 48627 48630 2-s2.0-0035966127 10.1074/jbc.C100556200
210. Walker S. M., Leslie N. R., Perera N. M., Batty I. H., Downes C. P., The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Biochemical Journal 2004 379 2 301 307 2-s2.0-2342631914 10.1042/BJ20031839 (Pubitemid 38570102)
211. Redfern R. E., Redfern D., Furgason M. L. M., Munson M., Ross A. H., Gericke A., PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes. Biochemistry 2008 47 7 2162 2171 2-s2.0-39649095159 10.1021/bi702114w (Pubitemid 351287142)
212. Vazquez F., Matsuoka S., Sellers W. R., Yanagida T., Ueda M., Devreotes P. N., Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. Proceedings of the National Academy of Sciences of the United States of America 2006 103 10 3633 3638 2-s2.0-33644870152 10.1073/pnas.0510570103 (Pubitemid 43376607)
213. Iijima M., Huang Y. E., Luo H. R., Vazquez F., Devreotes P. N., Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis. Journal of Biological Chemistry 2004 279 16 16606 16613 2-s2.0-1942501586 10.1074/jbc.M312098200 (Pubitemid 38509361)
214. Leslie N. R., Batty I. H., Maccario H., Davidson L., Downes C. P., Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 2008 27 41 5464 5476 2-s2.0-51849167782 10.1038/onc.2008.243
215. Lindsay Y., McCoull D., Davidson L., Leslie N. R., Fairservice A., Gray A., Lucocq J., Downes P., Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression. Journal of Cell Science 2006 119 24 5160 5168 2-s2.0-33845972919 10.1242/jcs.000133 (Pubitemid 46085194)
216. Sato M., Ueda Y., Takagi T., Umezawa Y., Production of PtdInsP3 at endomembranes is triggered by receptor endocytosis. Nature Cell Biology 2003 5 11 1016 1022 2-s2.0-0242441598 10.1038/ncb1054 (Pubitemid 37406916)
217. Mazzotti G., Zini N., Rizzi E., Rizzoli R., Galanzi A., Ognibene A., Santi S., Matteucci A., Martelli A. M., Maraldi N. M., Immunocytochemical detection of phosphatidylinositol 4,5-bisphosphate localization sites within the nucleus. Journal of Histochemistry and Cytochemistry 1995 43 2 181 191
218. Boronenkov I. V., Loijens J. C., Umeda M., Anderson R. A., Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing Pre-mRNA processing factors. Molecular Biology of the Cell 1998 9 12 3547 3560 2-s2.0-0031771547 (Pubitemid 28551047)
219. Lian Z., Di Cristofano A., Class reunion: PTEN joins the nuclear crew. Oncogene 2005 24 50 7394 7400 2-s2.0-27844535741 10.1038/sj.onc.1209089 (Pubitemid 41637979)
220. Gimm O., Perren A., Weng L. P., Marsh D. J., Jen Jen Yeh, Ziebold U., Gil E., Hinze R., Delbridge L., Lees J. A., Mutter G. L., Robinson B. G., Komminoth P., Dralle H., Eng C., Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. American Journal of Pathology 2000 156 5 1693 1700 2-s2.0-0033843623 (Pubitemid 30646707)
221. Perren A., Komminoth P., Saremaslani P., Matter C., Feurer S., Lees J. A., Heitz P. U., Eng C., Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. American Journal of Pathology 2000 157 4 1097 1103 2-s2.0-0033809990
222. Zhou X. P., Loukola A., Salovaara R., Nystrom-Lahti M., Peltomäki P., De la Chapelle A., Aaltonen L. A., Eng C., PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. American Journal of Pathology 2002 161 2 439 447 2-s2.0-0036968713 (Pubitemid 36142153)
223. Wang X., Trotman L. C., Koppie T., Alimonti A., Chen Z., Gao Z., Wang J., Erdjument-Bromage H., Tempst P., Cordon-Cardo C., Pandolfi P. P., Jiang X., NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 2007 128 1 129 139 2-s2.0-33845991111 10.1016/j.cell.2006.11.039 (Pubitemid 46048884)
224. Trotman L. C., Wang X., Alimonti A., Chen Z., Teruya-Feldstein J., Yang H., Pavletich N. P., Carver B. S., Cordon-Cardo C., Erdjument-Bromage H., Tempst P., Chi S. G., Kim H. J., Misteli T., Jiang X., Pandolfi P. P., Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007 128 1 141 156 2-s2.0-33845977965 10.1016/j.cell.2006.11.040 (Pubitemid 46048885)
225. Song M. S., Salmena L., Carracedo A., Egia A., Lo-Coco F., Teruya-Feldstein J., Pandolfi P. P., The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 2008 455 7214 813 817 2-s2.0-53649106156 10.1038/nature07290
226. Shen W. H., Balajee A. S., Wang J., Wu H., Eng C., Pandolfi P. P., Yin Y., Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007 128 1 157 170 2-s2.0-33845999615 10.1016/j.cell.2006.11.042 (Pubitemid 46048887)
227. Planchon S. M., Waite K. A., Eng C., The nuclear affairs of PTEN. Journal of Cell Science 2008 121 3 249 253 2-s2.0-40549118822 10.1242/jcs.022459 (Pubitemid 351356695)
228. Ahn J. Y., Rong R., Liu X., Ye K., PIKE/nuclear PI 3-kinase signaling mediates the antiapoptotic actions of NGF in the nucleus. EMBO Journal 2004 23 20 3995 4006 2-s2.0-8144228424 10.1038/sj.emboj.7600392 (Pubitemid 39472421)
229. Song M. S., Carracedo A., Salmena L., Song S. J., Egia A., Malumbres M., Pandolfi P. P., ppandolf@bidmc.harvard.edu Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 2011 144 2 187 199 10.1016/j.cell.2010.12.020
230. Bonifant C. L., Kim J. S., Waldman T., NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN. Journal of Cellular Biochemistry 2007 102 4 878 885 2-s2.0-35648982452 10.1002/jcb.21518 (Pubitemid 350036928)
231. Tolkacheva T., Boddapati M., Sanfiz A., Tsuchida K., Kimmelman A. C., Chan A. M. L., Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383. Cancer Research 2001 61 13 4985 4989 2-s2.0-0035394373 (Pubitemid 32681524)
232. von Stein W., Ramrath A., Grimm A., Müller-Borg M., Wodarz A., Direct association of Bazooka/PAR-3 with the lipid phosphatase PTEN reveals a link between the PAR/aPKC complex and phosphoinositide signaling. Development 2005 132 7 1675 1686 2-s2.0-17744386543 10.1242/dev.01720 (Pubitemid 40575867)
233. Valiente M., Andrés-Pons A., Gomar B., Torres J., Gil A., Tapparel C., Antonarakis S. E., Pulido R., Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. Journal of Biological Chemistry 2005 280 32 28936 28943 2-s2.0-23844473290 10.1074/jbc.M504761200 (Pubitemid 41161339)
234. Takahashi Y., Morales F. C., Kreimann E. L., Georgescu M. M., PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO Journal 2006 25 4 910 920 2-s2.0-33644504867 10.1038/sj.emboj.7600979 (Pubitemid 43292451)
235. Crockett D. K., Fillmore G. C., Elenitoba-Johnson K. S. J., Lim M. S., Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics. Proteomics 2005 5 5 1250 1262 2-s2.0-17044433895 10.1002/pmic.200401046
236. Wang X., Jiang X., Post-translational regulation of PTEN. Oncogene 2008 27 41 5454 5463 2-s2.0-51849155581 10.1038/onc.2008.242
237. Liu F., Wagner S., Campbell R. B., Nickerson J. A., Schiffer C. A., Ross A. H., PTEN enters the nucleus by diffusion. Journal of Cellular Biochemistry 2005 96 2 221 234 2-s2.0-26444498071 10.1002/jcb.20525 (Pubitemid 41437856)
238. Zhu Y., Hoell P., Ahlemeyer B., Krieglstein J., PTEN: a crucial mediator of mitochondria-dependent apoptosis. Apoptosis 2006 11 2 197 207 2-s2.0-33344476774 10.1007/s10495-006-3714-5 (Pubitemid 43291020)
239. Dempsey E. C., Newton A. C., Mochly-Rosen D., Fields A. P., Reyland M. E., Insel P. A., Messing R. O., Protein kinase C isozymes and the regulation of diverse cell responses. American Journal of Physiology 2000 279 3 L429 L438 2-s2.0-0033830338
240. Steinberg S. F., Structural basis of protein kinase C isoform function. Physiological Reviews 2008 88 4 1341 1378 2-s2.0-55949109631 10.1152/physrev.00034.2007
241. Battaini F., Pascale A., Protein kinase C signal transduction regulation in physiological and pathological aging. Annals of the New York Academy of Sciences 2005 1057 177 192 2-s2.0-32244440146 10.1196/annals.1356.011 (Pubitemid 43211634)
242. Stabel S., Parker P. J., Protein kinase C. Pharmacology and Therapeutics 1991 51 1 71 95 2-s2.0-0026091330
243. Nishizuka Y., Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992 258 5082 607 614 2-s2.0-0026451081
244. Giorgi C., Agnoletto C., Baldini C., Bononi A., Bonora M., Marchi S., Missiroli S., Patergnani S., Poletti F., Rimessi A., Zavan B., Pinton P., Redox control of protein kinase C: cell-and disease-specific aspects. Antioxidants and Redox Signaling 2010 13 7 1051 1085 2-s2.0-77955916237 10.1089/ars.2009.2825
245. Newton A. C., anewton@ucsd.edu Protein kinase C: poised to signal. American Journal of Physiology 2010 298 3 E395 E402 10.1152/ajpendo.00477.2009
246. Newton A. C., Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochemical Journal 2003 370 2 361 371 2-s2.0-0037337159 10.1042/BJ20021626 (Pubitemid 36315124)
247. Dutil E. M., Newton A. C., Dual role of pseudosubstrate in the coordinated regulation of protein kinase C by phosphorylation and diacylglycerol. Journal of Biological Chemistry 2000 275 14 10697 10701 2-s2.0-0034616296 10.1074/jbc.275.14.10697 (Pubitemid 30202138)
248. Hauge C., Antal T. L., Hirschberg D., Doehn U., Thorup K., Idrissova L., Hansen K., Jensen O. N., Jorgensen T. J., Biondi R. M., Frödin M., morten.frodin@bric.dk Mechanism for activation of the growth factor-activated AGC kinases by turn motif phosphorylation. EMBO Journal 2007 26 9 2251 2261 10.1038/sj.emboj.7601682 (Pubitemid 46685864)
249. Martelli A. M., Evangelisti C., Nyakern M., Manzoli F. A., Nuclear protein kinase C. Biochimica et Biophysica Acta 2006 1761 5-6 542 551 2-s2.0-33745226175 10.1016/j.bbalip.2006.02.009 (Pubitemid 43928860)
250. Rimessi A., Rizzuto R., Pinton P., Differential recruitment of PKC isoforms in HeLa cells during redox stress. Cell Stress and Chaperones 2007 12 4 291 298 2-s2.0-40749152802 10.1379/CSC-211.1
251. Breitkreutz D., Braiman-Wiksman L., Daum N., Denning M. F., Tennenbaum T., Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium. Journal of Cancer Research and Clinical Oncology 2007 133 11 793 808 2-s2.0-36849069894 10.1007/s00432-007-0280-3 (Pubitemid 350218916)
252. Toker A., Signaling through protein kinase C. Frontiers in Bioscience 1998 3 D1134 1147
253. Parton R. G., Simons K., The multiple faces of caveolae. Nature Reviews Molecular Cell Biology 2007 8 3 185 194 2-s2.0-33847181297 10.1038/nrm2122
254. Martelli A. M., Sang N., Borgatti P., Capitani S., Neri L. M., Multiple biological responses activated by nuclear protein kinase C. Journal of Cellular Biochemistry 1999 74 4 499 521 2-s2.0-0033567846 10.1002/(SICI)1097- 4644(19990915)74:4499::AID-JCB1>3.0.CO;2-X (Pubitemid 29372491)
255. Fernandez E., Cuenca N., Garcia M., De Juan J., Two types of mitochondria, are evidenced by protein kinase C immunoreactivity in the Muller cells of the carp retina. Neuroscience Letters 1995 183 3 202 205 2-s2.0-0028938590 10.1016/0304-3940(94)11151-8
256. Halestrap A. P., Calcium, mitochondria and reperfusion injury: a pore way to die. Biochemical Society Transactions 2006 34 2 232 237 2-s2.0-33645994183 10.1042/BST20060232
257. Machaca K., Ca2+ signaling, genes and the cell cycle. Cell Calcium 2010 48 5 243 250 2-s2.0-78649448791 10.1016/j.ceca.2010.10.003
258. Oancea E., Meyer T., Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell 1998 95 3 307 318 2-s2.0-0032582525 10.1016/S0092-8674(00)81763-8 (Pubitemid 28507320)
259. Montero M., Lobatón C. D., Gutierrez-Fernández S., Moreno A., Alvarez J., Modulation of histamine-induced Ca2+ release by protein kinase C: effects on cytosolic and mitochondrial [Ca2+] PEAKS. Journal of Biological Chemistry 2003 278 50 49972 49979 2-s2.0-0346749523 10.1074/jbc.M308378200 (Pubitemid 37548833)
260. Pinton P., Leo S., Wieckowski M. R., Di Benedetto G., Rizzuto R., Long-term modulation of mitochondrial Ca2+ signals by protein kinase C isozymes. Journal of Cell Biology 2004 165 2 223 232 2-s2.0-2142707179 10.1083/jcb.200311061 (Pubitemid 38544525)
261. Gopalakrishna R., Jaken S., Protein kinase C signaling and oxidative stress. Free Radical Biology and Medicine 2000 28 9 1349 1361 2-s2.0-0034190297 10.1016/S0891-5849(00)00221-5 (Pubitemid 30621479)
262. Pinton P., Rimessi A., Marchi S., Orsini F., Migliaccio E., Giorgio M., Contursi C., Minucci S., Mantovani F., Wieckowski M. R., Del Sal G., Pelicci P. G., Rizzuto R., Protein kinase C β and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007 315 5812 659 663 2-s2.0-33846817351 10.1126/science.1135380 (Pubitemid 46214712)
263. Frey M. R., Saxon M. L., Zhao X., Rollins A., Evans S. S., Black J. D., Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. Journal of Biological Chemistry 1997 272 14 9424 9435 2-s2.0-0030946540 10.1074/jbc.272.14.9424 (Pubitemid 27154957)
264. Nakagawa M., Oliva J. L., Kothapalli D., Fournier A., Assoian R. K., Kazanietz M. G., Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase C δ -dependent induction of p21. Journal of Biological Chemistry 2005 280 40 33926 33934 2-s2.0-26644461205 10.1074/jbc.M505748200 (Pubitemid 41443112)
265. Black J. D., Protein kinase C-mediated regulation of the cell cycle. Front Biosci 2000 5 D406 D423 2-s2.0-0034168037
266. Ali A. S., Ali S., El-Rayes B. F., Philip P. A., Sarkar F. H., Exploitation of protein kinase C: a useful target for cancer therapy. Cancer Treatment Reviews 2009 35 1 1 8 2-s2.0-58549113975 10.1016/j.ctrv.2008.07.006
267. Frey M. R., Clark J. A., Leontieva O., Uronis J. M., Black A. R., Black J. D., Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. Journal of Cell Biology 2000 151 4 763 777 2-s2.0-0034645064 10.1083/jcb.151.4.763
268. Clark J. A., Black A. R., Leontieva O. V., Frey M. R., Pysz M. A., Kunneva L., Woloszynska-Read A., Roy D., Black J. D., Involvement of the ERK Signaling Cascade in Protein Kinase C-mediated Cell Cycle Arrest in Intestinal Epithelial Cells. Journal of Biological Chemistry 2004 279 10 9233 9247 2-s2.0-1542275216 10.1074/jbc.M312268200 (Pubitemid 38295987)
269. Hizli A. A., Black A. R., Pysz M. A., Black J. D., Protein kinase C α signaling inhibits cyclin D1 translation in intestinal epithelial cells. Journal of Biological Chemistry 2006 281 21 14596 14603 2-s2.0-33744963882 10.1074/jbc.M601959200 (Pubitemid 43855163)
270. Solomon D. H., O'Brian C. A., Weinstein I. B., N- α -tosyl-L-lysine chloromethyl ketone and N- α -tosyl-L-phenylalanine chloromethyl ketone inhibit protein kinase C. FEBS Letters 1985 190 2 342 344 2-s2.0-0022246323 (Pubitemid 16257102)
271. Schwartz G. K., Jiang J., Kelsen D., Albino A. P., Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. Journal of the National Cancer Institute 1993 85 5 402 407 2-s2.0-0027536464 (Pubitemid 23073160)
272. Cacace A. M., Ueffing M., Philipp A., Han E. K. H., Kolch W., Weinstein I. B., PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. Oncogene 1996 13 12 2517 2526 2-s2.0-0030445276 (Pubitemid 27046108)
273. Watanabe T., Ono Y., Taniyama Y., Hazama K., Igarashi K., Ogita K., Kikkawa U., Nishizuka Y., Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C- δ subspecies. Proceedings of the National Academy of Sciences of the United States of America 1992 89 21 10159 10163 2-s2.0-0026472991 10.1073/pnas.89.21.10159
274. Humphries M. J., Limesand K. H., Schneider J. C., Nakayama K. I., Anderson S. M., Reyland M. E., Suppression of apoptosis in the protein kinase C δ null mouse in vivo. Journal of Biological Chemistry 2006 281 14 9728 9737 2-s2.0-33646901676 10.1074/jbc.M507851200 (Pubitemid 43864691)
275. Oster H., Leitges M., michael.leitges@mpihan.mpg.de Protein kinase C α but not PKC ζ suppresses intestinal tumor formation in Apc Min / + mice. Cancer Research 2006 66 14 6955 6963 10.1158/0008-5472.CAN-06-0268 (Pubitemid 44197670)
276. Heit I., Wieser R. J., Herget T., Faust D., Borchert-Stuhlträger M., Oesch F., Dietrich C., Involvement of protein kinase C δ in contact-dependent inhibition of growth in human and murine fibroblasts. Oncogene 2001 20 37 5143 5154 2-s2.0-0035939845 10.1038/sj.onc.1204657 (Pubitemid 32844043)
277. Hunter T., Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995 80 2 225 236 2-s2.0-0028838971
278. Hennessy B. T., Smith D. L., Ram P. T., Lu Y., Mills G. B., Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews Drug Discovery 2005 4 12 988 1004 2-s2.0-32044466838 10.1038/nrd1902